CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway. Chi F, Chen L, Jin X, He G, et al. Exp Cell Res 2022;412:113035.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chi F, Chen L, Jin X, He G, et al. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway. Exp Cell Res 2022;412:113035.
PMID: 35065924